EUVIMEDEUVIMED entdecken
Crossref

Evaluation of CD19+ CD24+CD27 B cell and serum level of interleukin 10 and interleukin 35 in patients with systemic lupus erythematosus

Nashwa S M Abdeen, Reham M A Abdalla, Heba M A Abdalla, Maha S Elnady, Samar A Tabra, Esraa Elshintenawy, Elham M Elbarky, Basant S Kasem, Reem M Awny, Rania S Amer

The Egyptian journal of Immunology · 01.04.2026 · 33 (2) · 33-42

DOI: 10.55133/eji.330204 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Egyptian journal of Immunology, online erschienen am 01.04.2026. Verfasst von Nashwa S M Abdeen und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pathology, Faculty of Medicine, Tanta University, Tanta, Egypt. Hauptthemen laut MEDLINE: Lupus Erythematosus, Systemic, Interleukin-10, Interleukins, B-Lymphocytes, Regulatory. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Regulatory B cells (Bregs) maintain immune homeostasis through anti-inflammatory cytokine production, yet their role in systemic lupus erythematosus (SLE) remains poorly understood. This study evaluated concentrations of CD19+CD24 high CD27+ regulatory B cell frequencies and serum interleukin-10 (IL-10) and interleukin-35 (IL-35) in 40 SLE patients compared to 25 normal controls. Patients in this cross-sectional observational study were stratified by SLE Disease Activity Index (SLEDAI) scores into Group I: SLE patients with active disease (≥5) and Group II: SLE patients with inactive disease (≤4) disease groups. CD19+CD24highCD27+ B cells were quantified by flow cytometry, while serum IL-10 and IL-35 levels by enzyme-linked immunosorbent assays. Active SLE patients demonstrated significantly reduced CD19+CD24 highCD27+ B cells (23.20×10⁶) compared to controls (56.40×10⁶, p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lupus Erythematosus, SystemicInterleukin-10InterleukinsB-Lymphocytes, RegulatoryHumansFemaleAdultMaleAntigens, CD19CD24 AntigenTumor Necrosis Factor Receptor Superfamily, Member 7Middle AgedYoung Adult

Substanzen

Interleukin-10interleukin-35, humanInterleukinsAntigens, CD19CD24 AntigenIL10 protein, humanTumor Necrosis Factor Receptor Superfamily, Member 7CD24 protein, humanCD19 molecule, human

Autor:innen und Institutionen

  • Department of Clinical Pathology, Faculty of Medicine, Tanta University, Tanta, Egypt.
  • Department of Internal Medicine, Faculty of Medicine, Tanta University, Tanta, Egypt.
  • Department of Microbiology and Immunology, Faculty of Medicine, Tanta University, Tanta, Egypt.
  • Department of Rheumatology, Rehabilitation and Physical Medicine, Faculty of Medicine, Tanta University, Tanta, Egypt.

Zitieren

APA

Abdeen, N. S. M., Abdalla, R. M. A., Abdalla, H. M. A., Elnady, M. S., Tabra, S. A., Elshintenawy, E., Elbarky, E. M., Kasem, B. S., Awny, R. M., & Amer, R. S. (2026). Evaluation of CD19+ CD24+CD27 B cell and serum level of interleukin 10 and interleukin 35 in patients with systemic lupus erythematosus. The Egyptian journal of Immunology, 33(2), 33-42. https://doi.org/10.55133/eji.330204

Vancouver

Abdeen NSM, Abdalla RMA, Abdalla HMA, Elnady MS, Tabra SA, Elshintenawy E, et al. Evaluation of CD19+ CD24+CD27 B cell and serum level of interleukin 10 and interleukin 35 in patients with systemic lupus erythematosus. The Egyptian journal of Immunology. 2026;33(2):33-42. doi:10.55133/eji.330204

BibTeX
@article{Abdeen2026,
  author = {Abdeen, Nashwa S M and Abdalla, Reham M A and Abdalla, Heba M A and Elnady, Maha S and Tabra, Samar A and Elshintenawy, Esraa and Elbarky, Elham M and Kasem, Basant S and Awny, Reem M and Amer, Rania S},
  title = {Evaluation of CD19+ CD24+CD27 B cell and serum level of interleukin 10 and interleukin 35 in patients with systemic lupus erythematosus},
  journal = {The Egyptian journal of Immunology},
  year = {2026},
  volume = {33},
  number = {2},
  pages = {33--42},
  doi = {10.55133/eji.330204}
}
Kostenlos starten →